These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 36082955)

  • 1. Power prior models for estimating response rates in a small n, sequential, multiple assignment, randomized trial.
    Chao YC; Braun TM; Tamura RN; Kidwell KM
    Stat Methods Med Res; 2022 Dec; 31(12):2297-2309. PubMed ID: 36082955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sample size determination for Bayesian analysis of small n sequential, multiple assignment, randomized trials (snSMARTs) with three agents.
    Wei B; Braun TM; Tamura RN; Kidwell K
    J Biopharm Stat; 2020 Nov; 30(6):1109-1120. PubMed ID: 32892710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addressing sequential and concurrent treatment regimens in a small n sequential, multiple assignment, randomized trial (snSMART) in the MISTIC study.
    Cheng Y; Tremoulet A; Burns J; Jain S
    J Biopharm Stat; 2023 Dec; ():1-19. PubMed ID: 38095587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic treatment regimens in small n, sequential, multiple assignment, randomized trials: An application in focal segmental glomerulosclerosis.
    Chao YC; Trachtman H; Gipson DS; Spino C; Braun TM; Kidwell KM
    Contemp Clin Trials; 2020 May; 92():105989. PubMed ID: 32200006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Bayesian analysis of small n sequential multiple assignment randomized trials (snSMARTs).
    Wei B; Braun TM; Tamura RN; Kidwell KM
    Stat Med; 2018 Nov; 37(26):3723-3732. PubMed ID: 30010207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian methods to compare dose levels with placebo in a small n, sequential, multiple assignment, randomized trial.
    Fang F; Hochstedler KA; Tamura RN; Braun TM; Kidwell KM
    Stat Med; 2021 Feb; 40(4):963-977. PubMed ID: 33216360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and analysis considerations for utilizing a mapping function in a small sample, sequential, multiple assignment, randomized trials with continuous outcomes.
    Hartman H; Tamura RN; Schipper MJ; Kidwell KM
    Stat Med; 2021 Jan; 40(2):312-326. PubMed ID: 33111381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A small n sequential multiple assignment randomized trial design for use in rare disease research.
    Tamura RN; Krischer JP; Pagnoux C; Micheletti R; Grayson PC; Chen YF; Merkel PA
    Contemp Clin Trials; 2016 Jan; 46():48-51. PubMed ID: 26586608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic enrichment of Bayesian small-sample, sequential, multiple assignment randomized trial design using natural history data: a case study from Duchenne muscular dystrophy.
    Wang S; Kidwell KM; Roychoudhury S
    Biometrics; 2023 Dec; 79(4):3612-3623. PubMed ID: 37323055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Bayesian meta-analytic approach for safety signal detection in randomized clinical trials.
    Odani M; Fukimbara S; Sato T
    Clin Trials; 2017 Apr; 14(2):192-200. PubMed ID: 28059578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporating individual historical controls and aggregate treatment effect estimates into a Bayesian survival trial: a simulation study.
    Brard C; Hampson LV; Gaspar N; Le Deley MC; Le Teuff G
    BMC Med Res Methodol; 2019 Apr; 19(1):85. PubMed ID: 31018832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Bayesian sequential design with adaptive randomization for 2-sided hypothesis test.
    Yu Q; Zhu L; Zhu H
    Pharm Stat; 2017 Nov; 16(6):451-465. PubMed ID: 28980435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified power prior with multiple historical trials for binary endpoints.
    Banbeta A; van Rosmalen J; Dejardin D; Lesaffre E
    Stat Med; 2019 Mar; 38(7):1147-1169. PubMed ID: 30360016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An adaptive power prior for sequential clinical trials - Application to bridging studies.
    Ollier A; Morita S; Ursino M; Zohar S
    Stat Methods Med Res; 2020 Aug; 29(8):2282-2294. PubMed ID: 31729275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of complex, partially nested clustering in a three-arm individually randomized group treatment trial: A case study with the wHOPE trial.
    Tong G; Seal KH; Becker WC; Li F; Dziura JD; Peduzzi PN; Esserman DA
    Clin Trials; 2022 Feb; 19(1):3-13. PubMed ID: 34693748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bayesian sample size calculations for comparing two strategies in SMART studies.
    Turchetta A; Moodie EEM; Stephens DA; Lambert SD
    Biometrics; 2023 Sep; 79(3):2489-2502. PubMed ID: 36511434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using horseshoe prior for incorporating multiple historical control data in randomized controlled trials.
    Ohigashi T; Maruo K; Sozu T; Gosho M
    Stat Methods Med Res; 2022 Jul; 31(7):1392-1404. PubMed ID: 35379046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian semiparametric meta-analytic-predictive prior for historical control borrowing in clinical trials.
    Hupf B; Bunn V; Lin J; Dong C
    Stat Med; 2021 Jun; 40(14):3385-3399. PubMed ID: 33851441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a multi-arm multi-stage Bayesian design for phase II drug selection trials - an example in hemato-oncology.
    Jacob L; Uvarova M; Boulet S; Begaj I; Chevret S
    BMC Med Res Methodol; 2016 Jun; 16():67. PubMed ID: 27250349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.